Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 879-886

  Schöttker, Ben ^a   Herder, Christian ^b   Müller, Heiko ^a   Brenner, Hermann ^a   Rothenbacher, Dietrich ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

AGED; CARDIOVASCULAR DISEASES; CREATININE; CYSTATIN C; DIABETES COMPLICATIONS; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 84862097605     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1998     Document Type: Article

References (40)

1. Aucella F, Guida CC, Lauriola V, Vergura M. How to assess renal function in the geriatric population. J Nephrol 2010;23(Suppl. 15): S46-S54
2. Selvin E, Ning Y, Steffes MW, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 2011;60:298-305
3. Wu I, Parikh CR. Screening for kidney diseases: older measures versus novel bio-markers. Clin J Am Soc Nephrol 2008;3:1895-1901
4. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens 2008;17:604-608
5. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100 (Pubitemid 41623371)
6. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. Amore accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
7. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-2483 (Pubitemid 43855050)
8. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
9. Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care 2006;29:1024-1030 (Pubitemid 44115239)
10. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006;116:288-296 (Pubitemid 43228342)
11. Thomas L, Huber AR. Renal function - estimation of glomerular filtration rate. Clin Chem Lab Med 2006;44:1295-1302 (Pubitemid 44706706)
12. Zhang QL, Brenner H, Koenig W, Rothenbacher D. Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations. Atherosclerosis 2010;211:342-347
13. Saran AM, DuBose TD Jr. Cardiovascular disease in chronic kidney disease. Ther Adv Cardiovasc Dis 2008;2:425-434
14. Silveiro SP, Araújo GN, Ferreira MN, Souza FD, Yamaguchi HM, Camargo EG. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation pronouncedly underestimates glomerular filtration rate in type 2 diabetes. Diabetes Care 2011;34:2353-2355
15. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006;48:392-401 (Pubitemid 44247251)
16. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97 (Pubitemid 47016250)
17. Zhang QL, Koenig W, Raum E, Stegmaier C, Brenner H, Rothenbacher D. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009;48:122-127
18. Herder C, Schöttker B, Rothenbacher D, et al. Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: results from the ESTHER study. Atherosclerosis 2011;216:244-247
19. Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol 2011;26:779-787
20. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient asmeasures of reliability. Educ Psychol Meas 1973;33:613-619
21. Yu PC, Bosnyak Z, Ceriello A. The importance of glycated haemoglobin (HbA (1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Diabetes Res Clin Pract 2010;89:1-9
22. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843 (Pubitemid 13033817)
23. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-935 (Pubitemid 46294733)
24. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a newmarker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172 (Pubitemid 351193639)
25. Cook NR. Methods for evaluating novel biomarkers - a new paradigm. Int J Clin Pract 2010;64:1723-1727
26. May S, Hosmer DW. A cautionary note on the use of the Grønnesby and Borgan goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal 2004;10:283-291 (Pubitemid 39073127)
27. Macisaac RJ, Premaratne E, Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev 2011;32:61-67
28. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and childrenda meta-analysis. Clin Biochem2007;40:383-391
29. Pucci L, Triscornia S, Lucchesi D, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 2007;53:480-488 (Pubitemid 46447945)
30. Chudleigh RA, Dunseath G, Evans W, et al. How reliable is estimation of glomerular filtration rate at diagnosis of type 2 diabetes? Diabetes Care 2007;30:300-305 (Pubitemid 46198334)
31. Rigalleau V, Lasseur C, Perlemoine C, et al. Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? Diabetes Care 2005;28:838-843 (Pubitemid 40434482)
32. Pugliese G, Solini A, Bonora E, et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis 2011;218:194-199
33. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75:652-660
34. Lee SH, Park SA, Ko SH, et al. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metabolism 2010;59:241-246
35. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart 2004;90:1398-1403 (Pubitemid 39626310)
36. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albuminto-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011;305:1545-1552
37. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005;51:321-327 (Pubitemid 40175801)
38. Tonelli M, Muntner P, Lloyd A, et al.; Alberta Kidney Disease Network. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med 2011;154:12-21
39. Cook NR, Paynter NP. Comments on 'Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers' by M. J. Pencina, R. B. D'Agostino, Sr. and E. W. Steyerberg. Stat Med 2012;31:93-95
40. Laakso M, Pyörälä K. Age of onset and type of diabetes. Diabetes Care 1985;8:114-117 (Pubitemid 15044006)